SonoScape Medical Corp
SZSE:300633
SonoScape Medical Corp
SZSE:300633
Price:
28.15
CNY
-0.14%
Market Closed
Market Cap:
¥12.2B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
SonoScape Medical Corp
SZSE:300633
|
CN |
|
Herige SA
PAR:ALHRG
|
FR |
|
R
|
Ravi Kumar Distilleries Ltd
NSE:RKDL
|
IN |
|
P
|
Poly Union Chemical Holding Group Co Ltd
SZSE:002037
|
CN |
|
elumeo SE
XETRA:ELB
|
DE |
|
Union Bank of India Ltd
NSE:UNIONBANK
|
IN |
|
M
|
M Yochananof and Sons 1988 Ltd
TASE:YHNF
|
IL |
|
Xinxiang Chemical Fiber Co Ltd
SZSE:000949
|
CN |
|
PharmaSGP Holding SE
XETRA:PSG
|
DE |
Income Statement
Earnings Waterfall
SonoScape Medical Corp
SonoScape Medical Corp
Income Statement
SonoScape Medical Corp
SonoScape Medical Corp
Currency: CNY
| Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||||||||||||||||||
| Interest Expense |
3
|
0
|
0
|
1
|
2
|
0
|
0
|
0
|
3
|
5
|
7
|
13
|
16
|
19
|
23
|
20
|
18
|
14
|
9
|
6
|
6
|
4
|
2
|
3
|
4
|
5
|
7
|
7
|
5
|
4
|
4
|
5
|
7
|
7
|
0
|
0
|
0
|
|
| Revenue |
719
N/A
|
785
+9%
|
885
+13%
|
963
+9%
|
989
+3%
|
1 060
+7%
|
1 106
+4%
|
1 144
+3%
|
1 227
+7%
|
1 226
0%
|
1 231
+0%
|
1 224
-1%
|
1 254
+2%
|
1 258
+0%
|
1 196
-5%
|
1 177
-2%
|
1 163
-1%
|
1 211
+4%
|
1 320
+9%
|
1 391
+5%
|
1 445
+4%
|
1 533
+6%
|
1 637
+7%
|
1 756
+7%
|
1 763
+0%
|
1 865
+6%
|
1 970
+6%
|
1 979
+0%
|
2 120
+7%
|
2 127
+0%
|
2 090
-2%
|
2 051
-2%
|
2 014
-2%
|
1 965
-2%
|
1 965
+0%
|
2 075
+6%
|
2 309
+11%
|
|
| Gross Profit | ||||||||||||||||||||||||||||||||||||||
| Cost of Revenue |
(256)
|
(278)
|
(300)
|
(320)
|
(316)
|
(342)
|
(362)
|
(363)
|
(381)
|
(397)
|
(393)
|
(421)
|
(444)
|
(458)
|
(450)
|
(429)
|
(410)
|
(420)
|
(444)
|
(470)
|
(533)
|
(525)
|
(555)
|
(607)
|
(624)
|
(602)
|
(638)
|
(624)
|
(684)
|
(669)
|
(675)
|
(676)
|
(786)
|
(759)
|
(782)
|
(855)
|
(920)
|
|
| Gross Profit |
464
N/A
|
506
+9%
|
585
+16%
|
644
+10%
|
673
+5%
|
719
+7%
|
744
+4%
|
781
+5%
|
846
+8%
|
829
-2%
|
838
+1%
|
803
-4%
|
810
+1%
|
800
-1%
|
746
-7%
|
748
+0%
|
753
+1%
|
791
+5%
|
875
+11%
|
921
+5%
|
911
-1%
|
1 008
+11%
|
1 083
+7%
|
1 149
+6%
|
1 138
-1%
|
1 263
+11%
|
1 332
+6%
|
1 355
+2%
|
1 436
+6%
|
1 458
+1%
|
1 414
-3%
|
1 375
-3%
|
1 228
-11%
|
1 205
-2%
|
1 184
-2%
|
1 220
+3%
|
1 389
+14%
|
|
| Operating Income | ||||||||||||||||||||||||||||||||||||||
| Operating Expenses |
(390)
|
(413)
|
(440)
|
(456)
|
(469)
|
(483)
|
(486)
|
(521)
|
(598)
|
(585)
|
(627)
|
(655)
|
(688)
|
(728)
|
(696)
|
(675)
|
(584)
|
(784)
|
(832)
|
(859)
|
(667)
|
(777)
|
(820)
|
(843)
|
(793)
|
(836)
|
(877)
|
(907)
|
(981)
|
(1 054)
|
(1 096)
|
(1 177)
|
(1 095)
|
(1 234)
|
(1 255)
|
(1 258)
|
(1 262)
|
|
| Selling, General & Administrative |
(251)
|
(334)
|
(376)
|
(390)
|
(347)
|
(493)
|
(513)
|
(527)
|
(438)
|
(476)
|
(440)
|
(475)
|
(501)
|
(503)
|
(476)
|
(451)
|
(411)
|
(394)
|
(435)
|
(458)
|
(466)
|
(474)
|
(501)
|
(518)
|
(543)
|
(573)
|
(597)
|
(611)
|
(668)
|
(694)
|
(725)
|
(775)
|
(693)
|
(727)
|
(724)
|
(725)
|
(796)
|
|
| Research & Development |
(134)
|
0
|
0
|
(105)
|
(177)
|
0
|
0
|
(63)
|
(223)
|
(188)
|
(250)
|
(242)
|
(244)
|
(258)
|
(253)
|
(261)
|
(228)
|
(238)
|
(247)
|
(251)
|
(250)
|
(279)
|
(294)
|
(314)
|
(316)
|
(333)
|
(342)
|
(350)
|
(368)
|
(406)
|
(427)
|
(459)
|
(453)
|
(497)
|
(505)
|
(501)
|
(474)
|
|
| Depreciation & Amortization |
(5)
|
0
|
0
|
0
|
(6)
|
0
|
0
|
0
|
(16)
|
0
|
0
|
0
|
(11)
|
0
|
0
|
0
|
(20)
|
0
|
0
|
0
|
(26)
|
0
|
0
|
0
|
(27)
|
0
|
0
|
0
|
(39)
|
0
|
0
|
0
|
(62)
|
0
|
0
|
0
|
(81)
|
|
| Other Operating Expenses |
(1)
|
(79)
|
(64)
|
39
|
61
|
10
|
27
|
70
|
78
|
79
|
63
|
62
|
68
|
33
|
33
|
37
|
75
|
(152)
|
(149)
|
(151)
|
75
|
(23)
|
(26)
|
(12)
|
93
|
70
|
61
|
54
|
94
|
45
|
56
|
57
|
112
|
(9)
|
(26)
|
(31)
|
89
|
|
| Operating Income |
73
N/A
|
93
+26%
|
145
+57%
|
188
+29%
|
204
+9%
|
235
+15%
|
259
+10%
|
260
+1%
|
248
-5%
|
244
-2%
|
211
-14%
|
148
-30%
|
122
-18%
|
72
-41%
|
50
-30%
|
73
+46%
|
170
+133%
|
7
-96%
|
44
+532%
|
62
+43%
|
245
+293%
|
231
-5%
|
263
+14%
|
306
+16%
|
346
+13%
|
427
+23%
|
455
+7%
|
447
-2%
|
455
+2%
|
403
-11%
|
318
-21%
|
197
-38%
|
133
-33%
|
(29)
N/A
|
(71)
-148%
|
(38)
+47%
|
127
N/A
|
|
| Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||
| Interest Income Expense |
8
|
6
|
5
|
4
|
3
|
(0)
|
14
|
27
|
24
|
20
|
12
|
3
|
5
|
10
|
3
|
(6)
|
(2)
|
(1)
|
(3)
|
2
|
8
|
(0)
|
22
|
34
|
37
|
50
|
34
|
20
|
36
|
33
|
42
|
44
|
45
|
47
|
50
|
53
|
38
|
|
| Non-Reccuring Items |
(2)
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(20)
|
0
|
0
|
0
|
(212)
|
0
|
0
|
0
|
(38)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(16)
|
0
|
0
|
0
|
(57)
|
0
|
0
|
0
|
(1)
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
61
|
48
|
39
|
20
|
0
|
(16)
|
(16)
|
(17)
|
(0)
|
(0)
|
(1)
|
1
|
1
|
1
|
1
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
39
|
39
|
38
|
38
|
0
|
(1)
|
(0)
|
(1)
|
(0)
|
(0)
|
(1)
|
(0)
|
(0)
|
(2)
|
(1)
|
(2)
|
(0)
|
|
| Pre-Tax Income |
141
N/A
|
147
+5%
|
189
+29%
|
213
+12%
|
208
-2%
|
219
+5%
|
257
+17%
|
271
+6%
|
271
+0%
|
263
-3%
|
222
-15%
|
152
-32%
|
108
-29%
|
83
-23%
|
54
-36%
|
67
+24%
|
(45)
N/A
|
5
N/A
|
41
+654%
|
64
+58%
|
254
+295%
|
269
+6%
|
323
+20%
|
378
+17%
|
382
+1%
|
475
+24%
|
489
+3%
|
465
-5%
|
474
+2%
|
436
-8%
|
360
-18%
|
240
-33%
|
120
-50%
|
16
-87%
|
(22)
N/A
|
14
N/A
|
164
+1 111%
|
|
| Net Income | ||||||||||||||||||||||||||||||||||||||
| Tax Provision |
(10)
|
(13)
|
(19)
|
(21)
|
(18)
|
(18)
|
(22)
|
(26)
|
(19)
|
(19)
|
(15)
|
(6)
|
(6)
|
(2)
|
1
|
(2)
|
(2)
|
(7)
|
(3)
|
2
|
(7)
|
(7)
|
(10)
|
(25)
|
(12)
|
(18)
|
(20)
|
(20)
|
(19)
|
(20)
|
(8)
|
2
|
22
|
34
|
40
|
53
|
33
|
|
| Income from Continuing Operations |
130
|
134
|
171
|
192
|
190
|
201
|
234
|
246
|
253
|
244
|
207
|
146
|
102
|
81
|
54
|
65
|
(46)
|
(2)
|
38
|
66
|
247
|
262
|
313
|
353
|
370
|
457
|
468
|
445
|
454
|
416
|
352
|
243
|
142
|
50
|
19
|
67
|
197
|
|
| Net Income (Common) |
130
N/A
|
134
+3%
|
171
+27%
|
192
+13%
|
190
-1%
|
201
+6%
|
234
+17%
|
246
+5%
|
253
+3%
|
244
-3%
|
207
-15%
|
146
-30%
|
102
-30%
|
81
-20%
|
54
-33%
|
65
+20%
|
(46)
N/A
|
(2)
+96%
|
38
N/A
|
66
+76%
|
247
+273%
|
262
+6%
|
313
+19%
|
353
+13%
|
370
+5%
|
457
+24%
|
468
+2%
|
445
-5%
|
454
+2%
|
416
-8%
|
352
-15%
|
243
-31%
|
142
-41%
|
50
-65%
|
19
-63%
|
67
+255%
|
197
+195%
|
|
| EPS (Diluted) |
0.36
N/A
|
0.38
+6%
|
0.46
+21%
|
0.48
+4%
|
0.49
+2%
|
0.5
+2%
|
0.58
+16%
|
0.61
+5%
|
0.63
+3%
|
0.61
-3%
|
0.52
-15%
|
0.37
-29%
|
0.25
-32%
|
0.21
-16%
|
0.14
-33%
|
0.16
+14%
|
-0.12
N/A
|
0
N/A
|
0.09
N/A
|
0.16
+78%
|
0.62
+287%
|
0.61
-2%
|
0.73
+20%
|
0.84
+15%
|
0.86
+2%
|
1.06
+23%
|
1.09
+3%
|
1.03
-6%
|
1.05
+2%
|
0.96
-9%
|
0.81
-16%
|
0.56
-31%
|
0.33
-41%
|
0.12
-64%
|
0.05
-58%
|
0.16
+220%
|
0.46
+188%
|
|
Switch to:
Switch to:
See Also
Discover More
